Thompson, M. C., Harrup, R. A., Coombs, C. C., Roeker, L. E., Pu, J. J., Choi, M. Y., … Mato, A. R. (2022). Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen. Blood Adv, 6(15), 4553–4557. https://doi.org/10.1182/bloodadvances.2022007812

Thompson, Meghan C., Rosemary A. Harrup, Catherine C. Coombs, Lindsey E. Roeker, Jeffrey J. Pu, Michael Y. Choi, Paul M. Barr, et al. “Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen.” Blood Adv 6, no. 15 (August 9, 2022): 4553–57. https://doi.org/10.1182/bloodadvances.2022007812.

Thompson MC, Harrup RA, Coombs CC, Roeker LE, Pu JJ, Choi MY, et al. Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen. Blood Adv. 2022 Aug 9;6(15):4553–7.

Thompson, Meghan C., et al. “Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen.” Blood Adv, vol. 6, no. 15, Aug. 2022, pp. 4553–57. Pubmed, doi:10.1182/bloodadvances.2022007812.

Thompson MC, Harrup RA, Coombs CC, Roeker LE, Pu JJ, Choi MY, Barr PM, Allan JN, Šimkovič M, Leslie L, Rhodes J, Chong EA, Kamdar M, Skarbnik A, Lansigan F, McCall B, Saja K, Dyer MJS, Walter HS, Lefebure M, Thadani-Mulero M, Boyer M, Biondo J, Sail K, Manzoor BS, Furman R, Bantilan KS, Goy A, Feldman T, Labella D, Schuster SJ, Park J, Palomba L, Zelenetz A, Eyre TA, Kater AP, Seymour JF, Mato AR. Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen. Blood Adv. 2022 Aug 9;6(15):4553–4557.